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Dear Sir,
We read with interest the article by Bednarska et al. in
which they assess the willingness of surgeons to participate
in an expertise-based randomized controlled trial (RCT) to
compare the effectiveness of high tibial osteotomy (HTO)
with unicompartmental knee arthroplasty (UKA) for treat-
ing isolated medial compartment osteoarthritis [2]. There
are, however, certain issues that require discussion and
consideration before one chooses this design.
The ﬁrst issue regards the validity of expertise-based
RCTs. It is claimed that expertise-based RCTs are less
biased than conventional RCTs because of the risks for
differential expertise biases in conventional RCTs [5].
Devereaux et al. argue that in a conventional RCT if there
are more surgeons experienced with one of the proce-
dures—which may be expected in practice—then the
estimate of the treatment effect will be biased in favor of
the preferred procedure [2]. We have several comments.
Foremost, the ﬁrst reason to perform a RCT is to dis-
tribute known and unknown confounders at random
between both treatment arms so that the difference mea-
sured will be that of the effect of treatment only. The ﬁrst
thing that an expertise-based RCT does is to break that rule
by attributing a different group of selected surgeons for
each treatment arm. Therefore, if there are differences
between the surgeons in the two groups, which is likely,
then this difference will systematically create a bias. In
fact, the low likelihood for differential expertise bias in an
expertise-based RCT assumes there is no interaction
between experience and treatment. In other words, the
inﬂuence of experience has the same effect in both treat-
ments. This hypothesis, however, may not be supportable.
For instance, in a recent analysis [3] of 496 patients of a
previously published trial [4] investigating the results of
three different uncemented total hip prosthesis systems, we
showed that an interaction between volume (a surrogate for
experience) and treatment occurred. What if surgeons who
are experienced in UKA were on average more skilled than
those experienced in HTO, or the opposite? We believe in
this case, the conventional RCT will yield a better esti-
mation of treatment effect. Second, we agree that a
differential expertise effect may occur in a conventional
RCT, but statistics can help us adjust and report that effect
instead of hiding it. In a comparative simulation of 1000
conventional RCTs and expertise-based RCTs, we found
that in a conventional RCT: (1) not accounting for exper-
tise yields a biased estimate of treatment effect (which is
the authors’point [2]), (2) adjusting the analysis for
expertise allows an unbiased estimation of treatment effect
and of the effect of expertise, and (3) accounting for
interaction when relevant allows an unbiased estimation of
treatment effect. In an expertise-based randomized RCT:
(1) there is no need to account for expertise to obtain an
unbiased estimate of treatment effect if there is no inter-
action, and (2) in case of interaction between expertise and
treatment, such effect cannot be separated from the effect
of treatment and the estimation of treatment effect is biased
(Table 1).
Another issue is the applicability of expertise-based
RCTs. Bednarska et al. theorize that expertise-based RCTs
are more representative of real life. Namely, that because in
reallifesurgeonspreferonetreatmentoveranother,itmakes
more sense that the trial only asks surgeons to perform their
preferred operation. To whom, however, is it relevant that
surgeons in the trial performed 100 UKAs or 50 HTOs a
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the treatment, then the results of the trial are applicable only
tothosewhoareexperiencedinthistreatment.Ifwewantthe
results to be applicable to others, they have to develop that
same experience. But how does one become experienced in
UKA if they treat only a few patients for unicompartmental
osteoarthritis? Assume that one has expertise in UKAs, that
the trial shows little superiority of HTOs, and that accord-
ingly, he or she isreadyto change his or herpractice to HTO
and allow for the necessary learning curve. How can one be
persuadedthathisorherexperiencewilleventuallycompare
with that of surgeons who chose to routinely perform HTOs,
given their previous preference to routinely perform UKAs?
DifferencesbetweensurgeonswhoperformHTOsandthose
who perform UKAs likely exist at all levels, such as the
inability to achieve the same preoperative care, surgical
skills, or postoperative care, and could prevent one from
obtaining the expected results. Allowing the design of the
trialtoincludesurgeonswithandwithoutexpertise(highand
low volume surgeons, etc), is more pragmatic and truly
representative of the application of surgical techniques in
real life.
Finally, there are ethical and practical issues with
expertise-based RCTs. The most prominent problem we
see with expertise-based RCTs is that of the patients’, and
not the surgeons’, willingness to participate. Large exper-
tise-based RCTs have been reported when both treatments
could not possibly be realized by the same care providers,
precluding a conventional RCT design, such as when
comparing coronary angioplasty with coronary artery
bypass surgery [1]. The four expertise-based RCTs con-
ducted in orthopaedics and cited by Bednarska et al. were
conducted in the emergency setting for treatment of frac-
tures [6–9]. In this particular case, patients had no plan to
go to the hospital and to be operated on that day and
therefore probably few demanded to be operated on by a
particular surgeon. In elective surgery, however, patients
often see a surgeon to whom they have been referred and
are willing to trust. Patients who see a surgeon for medial
compartment osteoarthritis probably would be reluctant to
be operated on by his or her colleague regardless of the
treatment offered. Therefore, the main drawbacks of
expertise-based RCTs limiting their feasibility and ethical
integrity are that patients have to accept that their treatment
will be determined at random, and they have half a chance
of not being treated by the surgeon they came to see. This,
we believe, is a major drawback of expertise-based RCTs
of most treatments we would like to study. This consider-
ation is probably different from one country to another
where sometimes patients are on waiting lists for surgery
and do not expect a speciﬁc surgeon to take care of them.
We agree with Bednarska et al. that researchers should
consider using expertise-based RCTs, but only after care-
fully considering their arguments and those above. There
are situations where expertise-based RCTs are more likely
to yield what the researchers are looking for, but for the
majority, conventional RCTs will answer the question
more easily and precisely.
References
1. Anonymous. Coronary angioplasty versus coronary artery bypass
surgery: the Randomized Intervention Treatment of Angina
(RITA) trial. Lancet. 1993;341:573–580.
2. Bednarska E, Bryant D, Devereaux PJ. Orthopaedic surgeons
prefer to participate in expertise-based randomized trials. Clin
Orthop Relat Res. 2008;466:1734–1744.
3. Biau DJ, Halm JA, Ahmadieh H, Capello WN, Jeekel J, Boutron I,
Porcher R. Provider and center effect in multicenter randomized
controlled trials of surgical specialties: an analysis on patient-level
data. Ann Surg. 2008;247:892–898.
Table 1. Estimation of treatment effect in 1000 simulated conventional and expertise-based randomized controlled trials
Statistical prediction models Trials simulated
Conventional RCTs
with expertise and
no interaction
Conventional RCTs
with expertise and
interaction
Expertise-based RCTs
with expertise and
no interaction
Expertise-based
RCTs with expertise
and interaction
Not adjusted 4.01 (1.52) 3.55 (1.53) 5.02 (1.60) 5.14 (1.59)
Adjusted for expertise 4.99 (1.63) 4.55 (1.68) — —
Adjusted for expertise and interaction 4.94 (2.31) 5.02 (2.33) — —
The trial simulated was a comparison of the 3 months postoperative Knee Society Score (KSS) between HTOs (control group) and UKAs
(experimental group). The mean KSS simulated was 75 (sd = 10) in the control group and 80 (sd = 10) in the experimental group. Therefore, the
true treatment effect is 5. In the conventional RCT, seven surgeons were experienced with the control treatment and three with the experimental
treatment. The effect of expertise was to add 2.5 points to the KSS for surgeons with expertise in both treatments when there was no interaction
between treatment and expertise. When there was interaction between expertise and treatment, 2 points of the KSS were added to the control
group and 3 to the experimental group. Expertise cannot be accounted for in the expertise-based RCT because all surgeons have expertise. It can
be seen that the estimation of treatment effect is unbiased for conventional RCTs when adjusted for expertise (4.99) and interaction (5.02). The
estimation of treatment effect is also unbiased for expertise-based RCTs with no interaction present (5.02). However, the estimation of treatment
effect for expertise based RCTs is biased when interaction is present (5.14).
Volume 467, Number 1, January 2009 Letter to the Editor 299
1234. Capello WN, Dantonio JA, Feinberg JR, Manley MT. Alternative
bearing surfaces: alumina ceramic bearings for total hip arthro-
plasty. Instr Course Lect. 2005;54:171–176.
5. Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ,
Yusuf S, Sackett DL, Cina CS, Walter SD, Haynes B, Schunemann
HJ, Norman GR, Guyatt GH. Need for expertise based randomised
controlled trials. BMJ. 2005;330:88.
6. Finkemeier CG, Schmidt AH, Kyle RF, Templeman DC, Varecka
TF.Aprospective,randomizedstudyofintramedullarynailsinserted
with and without reaming for the treatment of open and closed
fractures of the tibial shaft. J Orthop Trauma. 2000;14:187–193.
7. Phillips WA, Schwartz HS, Keller CS, Woodward HR, Rudd WS,
Spiegel PG, Laros GS. A prospective, randomized study of the
management of severe ankle fractures. J Bone Joint Surg Am.
1985;67:67–78.
8. Wihlborg O. Fixation of femoral neck fractures: a four-ﬂanged nail
versus threaded pins in 200 cases. Acta Orthop Scand. 1990;61:
415–418.
9. Wyrsch B, McFerran MA, McAndrew M, Limbird TJ, Harper MC,
Johnson KD, Schwartz HS. Operative treatment of fractures of the
tibial plafond: a randomized, prospective study. J Bone Joint Surg
Am. 1996;78:1646–1657.
300 Biau and Porcher Clinical Orthopaedics and Related Research
123